The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Longevity - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)
Developing outcome centric, territory-specific access protocols for the provision of niche product - John Bardsley (2021 Conference) (LDN, low dose naltrexone)
John Bardsley is managing director of Thistle Pharma Ltd. LDN is an unlicensed medicine. Much of what he is talking about pertains specifically to the UK sector, and may apply to your own territories as well.
Delivery Systems - Yusuf Saleeby, MD (2021 Conference) (LDN, low dose naltrexone)
In this presentation, Dr. Saleeby discusses different delivery systems for Naltrexone/LDN and ultra low dose Naltrexone, the nuances for the different types of delivery systems, and how to best write a professional compounding prescription.
Terry Wingo - LDN Specialist, LDN Radio Show 20 April 2021 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Terry Wingo graduated from Auburn University in 1975 with a bachelor of science in Pharmacy. He has fellowships with the American College of Apothecaries and the American College of Veterinary Pharmacists.
Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone (2019 Conference) (LDN, low dose naltrexone)
Tara Thompson, PharmD discusses the purpose of a compounding pharmacy, how to choose one, the benefits and limitations of compounding, and dosage forms. She give an overview of naltrexone, dosing of LDN in various conditions, and how to write a prescription for compounded naltrexone.
LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)
Presentations on the below and questions were asked in relation to:
Stephen Dickson, BSC (hons) MRPharmS - Mechanism of Action of Low Dose Naltrexone (2019 Conference) (LDN, low dose naltrexone)
LDN 2019 Conference - Saturday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)
Presentations on the below and questions were asked in relation to: